About: Abstract The effect of varying corticosteroid regimens on hip osteonecrosis incidence remains unclear. We performed a meta-analysis and systematic literature review to determine osteonecrosis occurrences in patients taking corticosteroids at varying mean and cumulative doses and treatment durations, and whether medical diagnoses affected osteonecrosis incidence. Fifty-seven studies (23,561 patients) were reviewed. Regression analysis determined significance between corticosteroid usage and osteonecrosis incidence. Osteonecrosis incidence was 6.7% with corticosteroid treatment of >2 g (prednisone-equivalent). Systemic lupus erythematosus patients had positive correlations between dose and osteonecrosis incidence. Each 10 mg/d increase was associated with a 3.6% increase in osteonecrosis rate, and >20 mg/d resulted in a higher osteonecrosis incidence. Clinicians must be wary of osteonecrosis in patients on high corticosteroid regimens, particularly in systematic lupus erythematosus.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Abstract The effect of varying corticosteroid regimens on hip osteonecrosis incidence remains unclear. We performed a meta-analysis and systematic literature review to determine osteonecrosis occurrences in patients taking corticosteroids at varying mean and cumulative doses and treatment durations, and whether medical diagnoses affected osteonecrosis incidence. Fifty-seven studies (23,561 patients) were reviewed. Regression analysis determined significance between corticosteroid usage and osteonecrosis incidence. Osteonecrosis incidence was 6.7% with corticosteroid treatment of >2 g (prednisone-equivalent). Systemic lupus erythematosus patients had positive correlations between dose and osteonecrosis incidence. Each 10 mg/d increase was associated with a 3.6% increase in osteonecrosis rate, and >20 mg/d resulted in a higher osteonecrosis incidence. Clinicians must be wary of osteonecrosis in patients on high corticosteroid regimens, particularly in systematic lupus erythematosus. Goto Sponge NotDistinct Permalink

An Entity of Type : fabio:Abstract, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	abstract
value	Abstract The effect of varying corticosteroid regimens on hip osteonecrosis incidence remains unclear. We performed a meta-analysis and systematic literature review to determine osteonecrosis occurrences in patients taking corticosteroids at varying mean and cumulative doses and treatment durations, and whether medical diagnoses affected osteonecrosis incidence. Fifty-seven studies (23,561 patients) were reviewed. Regression analysis determined significance between corticosteroid usage and osteonecrosis incidence. Osteonecrosis incidence was 6.7% with corticosteroid treatment of >2 g (prednisone-equivalent). Systemic lupus erythematosus patients had positive correlations between dose and osteonecrosis incidence. Each 10 mg/d increase was associated with a 3.6% increase in osteonecrosis rate, and >20 mg/d resulted in a higher osteonecrosis incidence. Clinicians must be wary of osteonecrosis in patients on high corticosteroid regimens, particularly in systematic lupus erythematosus.
Subject	Steroids Corticosteroids Endocrinology Osteonecrosis Risk factors Meta-analysis Systematic review Steroid hormones Hormones Diving medicine Evidence-based practices Medical statistics Osteopathies RTT RTTEM World Anti-Doping Agency prohibited substances
part of	High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review
is abstract of	High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review
is hasSource of	covid:ann/target/23c7ebfd96b3332d6662d24301cb942b4ea299f0 covid:ann/target/5246e73f1e316039738c800a9291f18673f37808 covid:ann/target/a327190d9c250bbfe13b9a046d0689c6802019db covid:ann/target/49a2b3470d5036655d132028634bdb6e8209900c covid:ann/target/670e93e83abff7586eb503680adee0b5a3d3189d covid:ann/target/5817afcaf1fe2c690d001d10e4a3d81fa2d1b56e covid:ann/target/ba67d1e404ca951b84b8e30dde5b266da97e3f78 covid:ann/target/48d748d9107ef49b6f8c937b6321823f65919df3 covid:ann/target/36ef233d068c79f5b6e478067254229109212f46 covid:ann/target/d71508c87672ca2a0fc99a138d10fb56121638a4 covid:ann/target/e2c69cc3b2b87aba350e05a532e10de0dafaec34 covid:ann/target/6f356e7d82f2e750802e819f298a08ce86da47e0 covid:ann/target/11bb6083390b3231de7813b68b3f98ea07bf5b10 covid:ann/target/583defaa29e12491623a519c843a970a1d47e9c2 covid:ann/target/2163a9a6022657e68637b608ac6350ce98f179b3

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software